MARKETS
Markets

Opus Genetics Files Prospectus To Sell $300M Mixed Securities Shelf Including 34.5M Shares

Aug 7, 2026 · 06:33 AM ET· updated 1h ago

Common StockPreferred StockDebt SecuritiesWarrantsUnitsand up to 34,449,749 Shares of Common Stock Issuable Upon Exercise ofWarrants and Pre-Funded Warrants Offered, from time to time, by OpusGenetics, Inc.

Share
Why It Matters

Opus Genetics is getting permission to sell up to $300 million in different types of company ownership and debt over time, which means they're raising money for their business. When a company does this, it's worth watching whether they actually use the money well and how fast they spend it.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.